Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,699 | -30,070 | -85,981 | -70,830 | -50,420 |
| Depreciation Amortization | 1,507 | 862 | 2,641 | 2,378 | 1,957 |
| Accounts receivable | N/A | N/A | 110 | 110 | 110 |
| Accounts payable and accrued liabilities | 31 | 2,745 | -5,246 | 660 | 373 |
| Other Working Capital | -7,577 | -905 | -3,689 | -746 | 1,218 |
| Other Operating Activity | 5,278 | -627 | -5,812 | 4,931 | 3,694 |
| Operating Cash Flow | $-55,460 | $-27,995 | $-97,977 | $-63,497 | $-43,068 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,930 | 37,766 | 30,049 | -5,384 | -20,532 |
| PPE Investments | -1,042 | -506 | -2,415 | -1,559 | -1,320 |
| Net Acquisitions | N/A | N/A | 31,523 | N/A | N/A |
| Investing Cash Flow | $-10,972 | $37,260 | $59,157 | $-6,943 | $-21,852 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,143 | N/A | N/A |
| Common Stock Issued | 2,539 | N/A | 72,573 | 22 | 22 |
| Other Financing Activity | 78 | 0 | 115 | 72 | 73 |
| Financing Cash Flow | $2,617 | $N/A | $74,831 | $94 | $95 |
| Beginning Cash Position | 157,217 | 157,217 | 121,206 | 121,206 | 121,206 |
| End Cash Position | 93,402 | 166,482 | 157,217 | 50,860 | 56,381 |
| Net Cash Flow | $-63,815 | $9,265 | $36,011 | $-70,346 | $-64,825 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,460 | -27,995 | -97,977 | -63,497 | -43,068 |
| Capital Expenditure | -1,042 | -506 | -3,015 | -2,159 | -1,320 |
| Free Cash Flow | -56,502 | -28,501 | -100,992 | -65,656 | -44,388 |